![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
University Hospital, Angers |
---|---|
Information provided by: | University Hospital, Angers |
ClinicalTrials.gov Identifier: | NCT00152646 |
The aim of the study is to show the implication of platelets in vasodilation using in vivo and in vitro analysis and to compare the effects of placebo, aspirin and Clopidogrel in this interaction platelets/vessels.
The effects of 7 days of each treatment will be compared in healthy subjects and patients with arteriopathy.
Condition | Intervention | Phase |
---|---|---|
Arteriopathy |
Drug: placebo, aspirine, clopidogrel |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Efficacy Study |
Official Title: | Platelets Induced Vasodilation, in Vitro and in Vivo Study in Patients With Arteriopathy and Healthy Subjects. |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Inclusion criteria healthy subjects
Inclusion criteria healthy subjects
Exclusion Criteria:
France, Maine et Loire | |
Exploration Fonctionnelles Vasculaires | Recruiting |
Angers, Maine et Loire, France, 49933 | |
Contact: Marc Antoine Custaud, MD PhD 33241353689 macustaud@chu-angers.fr |
Principal Investigator: | Marc Antoine Custaud, MD PhD | CHU ANGERS |
Study ID Numbers: | PHRC 04-07 |
Study First Received: | September 7, 2005 |
Last Updated: | September 7, 2005 |
ClinicalTrials.gov Identifier: | NCT00152646 |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
Clopidogrel Healthy |
Therapeutic Uses Hematologic Agents Platelet Aggregation Inhibitors Pharmacologic Actions |